MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Diagnostics-Operating Segments$2,900,700K (5.53%↑ Y/Y)Biopharma LaboratoryServices-Operating Segments$836,200K (6.55%↑ Y/Y)Revenues$3,731,100K (5.78%↑ Y/Y)Intersegment Elimination-$5,800K (7.94%↑ Y/Y)Gross profit$1,112,000K (6.29%↑ Y/Y)Cost of revenues$2,619,100K (5.56%↑ Y/Y)Operating income$451,600K (14.47%↑ Y/Y)Investment income$5,600K (229.41%↑ Y/Y)Selling, general, andadministrative expenses$577,200K (-0.36%↓ Y/Y)Amortization of intangiblesand other assets$78,100K (14.35%↑ Y/Y)Restructuring and othercharges$5,100K (24.39%↑ Y/Y)Earnings from operationsbefore income taxes$386,400K (26.81%↑ Y/Y)Interest expense$61,100K (7.01%↑ Y/Y)Equity method loss, net-$6,200K (-264.71%↓ Y/Y)Other, net-$3,500K (89.30%↑ Y/Y)Net earnings$299,100K (25.51%↑ Y/Y)Provision for income taxes$87,300K (31.48%↑ Y/Y)Net earningsattributable to labcorp...$298,700K (25.56%↑ Y/Y)Less net earningsattributable to the...$400K (0.00%↑ Y/Y)
Income Statement
Labcorp_Logo-svg

LABCORP HOLDINGS INC. (LH)

Labcorp_Logo-svg

LABCORP HOLDINGS INC. (LH)

source: myfinsight.com